Tools

LEADER 04121cam 2200505 a 4500

001 ssj0000679317;

003 WaSeSS;

005 20190313051101.0;

006 m d ;

007 cr n ;

008 111222s2012 nju sb 001 0 eng d;

010 a| 2011052987;

020 a| 9781118309407 ( epub);

020 a| 9781118309384 (epdf);

020 a| 9781118309391 (emobi);

020 z| 9780470322826 (cloth);

035 a| (WaSeSS)ssj0000679317;

042 a| pcc;

049 a| EREEa| NEHH;

050 00 a| RC514;

060 10 a| WM 203;

082 00 a| 616.89/80612| 23;

245 00 a| Targets and emerging therapies for schizophreniah| [electronic resource] /c| edited by Jeffrey S. Albert, Michael W. Wood.;

260 a| Hoboken, New Jersey :b| John Wiley & Sons,;

300 a| 1 online resource.;

504 a| Includes bibliographical references and index.;

505 0 a| Dopaminergic hypothesis of schizophrenia : a historical perspective / Aurelija Jucaite and Svante Nyberg -- Dopamine D2/D3 partial agonists as antipsychotics / Philip G. Strange -- D1/D5 dopamine agonists as pharmacotherapy for schizophrenia / Kevin N. Boyd and Richard B. Mailman -- PDE inhibitors as a novel therapeutic approach for schizophrenia / Judith A. Siuciak and William J. Pitts -- Glutamatergic synaptic dysregulation in schizophrenia / Joseph T. Coyle, Alo Basu, and Michael Benneyworth -- Metabotropic glutamate 2/3 receptor agonists and positive allosteric modulators of metabotropic glutamate receptor 2 as novel agents for the treatment of schizophrenia / Gerard J. Marek ... [et al.] -- AMPA receptor positive modulators / John A. Morrow, John K.F. Maclean, and Craig Jamieson -- Progress in the exploration and development of GlyT1 inhibitors for schizophrenia / Jeffrey S. Albert and Michael W. Wood -- Combined dopamine D2 and 5-hydroxytryptamine (5-HT)1a receptor strategies for the treatment of schizophrenia, a pharmacological and chemical perspective / Andrew C. Mccreary, Roelof W. Feenstra, and Caitlin A. Jones -- 5-HT2C and 5-HT6 receptor targeted emerging approaches in schizophrenia / Sharon Rosenzweig-Lipson ... [et al.] -- The cholinergic hypothesis : an introduction to the hypothesis and a short history / Joseph I. Friedman, Isabella Kanellopoulou, and Vladan Novakovic -- À7 nicotinic acetylcholine receptors in the treatment of schizophrenia / Mihály Hajós, and Bruce N. Rogers -- Muscarinic acetylcholine receptors as novel targets for the development of therapeutics for schizophrenia / Christian C. Felder ... [et al.] -- Will modulation of neuropeptide receptors produce the next generation of antipsychotic drugs? : a focus on the neurokinin and neurotensin systems / Lee A. Dawson, Paul W. Smith, and Jeannette M. Watson -- GABA and schizophrenia / John H. Kehne and George D. Maynard.;

506 a| Available only to authorized users.;

538 a| Mode of access: World Wide Web;

588 a| Description based on print version record and CIP data provided by publisher.;

650 12 a| Schizophreniax| drug therapy.=| ^A923199;

655 0 a| Electronic books.=| ^A491897;

700 1 a| Albert, Jeffrey S.=| ^A1118366;

700 1 a| Wood, Michael W.q| (Michael William),d| 1961-=| ^A1118364;

856 40 z| Full text available from Ebook Central - Academic Completeu| https://ebookcentral.proquest.com/lib/eastcarolina/detail.action?docID=843663;

949 a| CLICK ON WEB ADDRESSw| ASISh| JOYNER188;

949 a| CLICK ON WEB ADDRESSw| ASISh| HSL77;

949 a| CLICK ON WEB ADDRESSw| ASISh| JMUSIC60;

596 a| 1 3 4;

998 a| 4295930;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 4295930-1001l| JNETm| JOYNERr| Ys| Yt| JNESSBKu| 1/4/2016x| EBOOKz| JERESOURCE;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 4295930-2001l| HSLELECm| HSLr| Ys| Yt| HEBKu| 1/4/2016x| EBOOKz| HERESOURCE;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 4295930-3001l| MNETm| JMUSICr| Ys| Yt| MNESSBKu| 1/4/2016x| EBOOKz| JERESOURCE;

Targets and emerging therapies for schizophrenia / edited by Jeffrey S. Albert, Michael W. Wood.

Other author	Albert, Jeffrey S.
Other author	Wood, Michael W. (Michael William), 1961-
Format	Electronic
Publication Info	Hoboken, New Jersey : John Wiley & Sons,
Description	1 online resource.
Supplemental Content	Full text available from Ebook Central - Academic Complete
Subjects	Schizophrenia--drug therapy.

Contents	Dopaminergic hypothesis of schizophrenia : a historical perspective / Aurelija Jucaite and Svante Nyberg -- Dopamine D2/D3 partial agonists as antipsychotics / Philip G. Strange -- D1/D5 dopamine agonists as pharmacotherapy for schizophrenia / Kevin N. Boyd and Richard B. Mailman -- PDE inhibitors as a novel therapeutic approach for schizophrenia / Judith A. Siuciak and William J. Pitts -- Glutamatergic synaptic dysregulation in schizophrenia / Joseph T. Coyle, Alo Basu, and Michael Benneyworth -- Metabotropic glutamate 2/3 receptor agonists and positive allosteric modulators of metabotropic glutamate receptor 2 as novel agents for the treatment of schizophrenia / Gerard J. Marek ... [et al.] -- AMPA receptor positive modulators / John A. Morrow, John K.F. Maclean, and Craig Jamieson -- Progress in the exploration and development of GlyT1 inhibitors for schizophrenia / Jeffrey S. Albert and Michael W. Wood -- Combined dopamine D2 and 5-hydroxytryptamine (5-HT)1a receptor strategies for the treatment of schizophrenia, a pharmacological and chemical perspective / Andrew C. Mccreary, Roelof W. Feenstra, and Caitlin A. Jones -- 5-HT2C and 5-HT6 receptor targeted emerging approaches in schizophrenia / Sharon Rosenzweig-Lipson ... [et al.] -- The cholinergic hypothesis : an introduction to the hypothesis and a short history / Joseph I. Friedman, Isabella Kanellopoulou, and Vladan Novakovic -- À7 nicotinic acetylcholine receptors in the treatment of schizophrenia / Mihály Hajós, and Bruce N. Rogers -- Muscarinic acetylcholine receptors as novel targets for the development of therapeutics for schizophrenia / Christian C. Felder ... [et al.] -- Will modulation of neuropeptide receptors produce the next generation of antipsychotic drugs? : a focus on the neurokinin and neurotensin systems / Lee A. Dawson, Paul W. Smith, and Jeannette M. Watson -- GABA and schizophrenia / John H. Kehne and George D. Maynard.
Bibliography note	Includes bibliographical references and index.
Access restriction	Available only to authorized users.
Technical details	Mode of access: World Wide Web
Source of description	Description based on print version record and CIP data provided by publisher.
Issued in other form	Print version: Targets and emerging therapies for schizophrenia Hoboken, N.J. : John Wiley & Sons, c2012 9780470322826 (cloth)
Genre/form	Electronic books.
LCCN	2011052987
ISBN	9781118309407 ( epub)
ISBN	9781118309384 (epdf)
ISBN	9781118309391 (emobi)

Targets and emerging therapies for schizophrenia / edited by Jeffrey S. Albert, Michael W. Wood.

Click here for more information about this title